12 Health Care Stocks Moving In Wednesday's Pre-Market Session

BenzingaNov 27 16:05 ET

TuHURA Biosciences Advances in Cancer Immunotherapy Innovations

TipRanksNov 25 09:27 ET

TuHURA Biosciences Expects to Complete Enrollment for REM-001 Study in Q4

TipRanksNov 25 08:51 ET

TuHURA Biosciences Sees Cash Runway Into 2H25

TipRanksNov 25 08:50 ET

TuHURA Biosciences Outlines Development Pathway for IFx-2.0

TipRanksNov 25 08:45 ET

TuHURA Biosciences Outlines Development Pathway For Single Phase 3 Accelerated Approval Registration Trial

BenzingaNov 25 08:40 ET